Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing follows a titration schedule designed to minimize side effects while maximizing weight loss and metabolic benefits. Most patients begin at the lowest concentration and progress upward based on tolerance and clinical response over 12 to 16 weeks. PlexusDx compounds semaglutide in multiple strengths to match your individual needs without charging more as your dose increases.

How Compounded Semaglutide Dosing Typically Works

Compounded semaglutide injections are administered once weekly, with dosing escalation happening every four weeks. The standard protocol moves through four or five dose levels, starting at 0.25 mg and advancing to maintenance doses of 0.5 mg, 1.0 mg, 1.5 mg, or 2.0 mg depending on your response and tolerance. This gradual approach allows your body to adapt and reduces gastrointestinal side effects that occur more frequently with rapid dose jumps.

Your specific dosing path depends on baseline health markers, body weight, metabolic rate, and how your GLP-1 receptors respond to the medication. Some patients plateau at 1.0 mg and achieve their goals without needing higher doses, while others benefit from reaching 2.0 mg or combining semaglutide with complementary compounds. PlexusDx providers assess your progress at regular intervals and adjust your dose accordingly—your dose may need to go up, but your price won't.

Understanding the Four-Week Titration Schedule

Week one through four typically involves your starting dose of 0.25 mg injected subcutaneously once per week. During this first month, your body begins signaling satiety through GLP-1 receptor activation in your brain, and your appetite naturally decreases. Most patients notice reduced hunger and improved eating patterns by week two or three, though weight loss during this phase is modest since the dose remains subtherapeutic.

Weeks five through eight introduce the 0.5 mg dose, which is considered the minimum effective dose for weight reduction in clinical research. This dose level delivers more robust appetite suppression and often produces noticeable weekly weight loss of 0.5 to 2 pounds depending on your baseline metabolism and adherence to dietary changes. If side effects remain minimal, your provider schedules advancement to 1.0 mg at week nine.

Maintenance Dosing Ranges and Individual Variation

Maintenance doses for compounded semaglutide typically range from 1.0 mg to 2.0 mg weekly, though some patients achieve optimal results at intermediate doses like 1.5 mg. Reaching your maintenance dose does not happen overnight; the progression from 0.5 mg to 1.5 mg or 2.0 mg spans 8 to 12 additional weeks to ensure tolerability. Clinical trials show that higher doses produce greater weight loss, but the difference between 1.5 mg and 2.0 mg may be modest for certain individuals.

PlexusDx recognizes that optimal dosing is not one-size-fits-all. Some patients with certain genetic profiles respond exceptionally well to lower doses, while others with different metabolic pathways require higher concentrations to achieve significant weight reduction. Your PlexusDx provider monitors your response metrics and adjusts timing and dose strength based on your individual progress, side effect profile, and long-term goals.

PlexusDx Compounded Semaglutide Pricing and Dosing Flexibility

PlexusDx compounds semaglutide injections starting at $149 per month across all dose levels. Whether you are on your starting 0.25 mg dose or your maintenance 2.0 mg dose, your monthly investment remains flat with no surprise cost increases as your provider adjusts your strength. This pricing model removes the financial barrier to dose optimization and encourages patients to escalate safely without concern about affordability.

All PlexusDx medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and accuracy at every dose level. PlexusDx serves all 50 states with no insurance requirement, no membership fee, and HSA/FSA eligibility, making personalized semaglutide therapy accessible regardless of your insurance status. Your dose may need to go up; your price won't.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of compounded semaglutide?

The standard starting dose is 0.25 mg injected subcutaneously once per week. This low initial dose minimizes nausea and allows your body to acclimate to GLP-1 receptor activation. PlexusDx providers advance your dose every four weeks based on your tolerance and weight loss response.

How long does it take to reach maintenance dosing?

Most patients progress through the titration schedule over 12 to 16 weeks, moving from 0.25 mg through 0.5 mg, 1.0 mg, and potentially 1.5 mg or 2.0 mg. The four-week intervals between each increase allow adequate time to assess tolerability and efficacy before advancing further.

Will my price increase if my dose goes higher?

No. PlexusDx charges a flat monthly rate of $149 for compounded semaglutide injections regardless of your dose level. Your dose may need to go up as your treatment progresses, but your price won't change, ensuring transparent and predictable costs throughout your therapy.

Can I stop escalating if I feel good at a lower dose?

Yes. If you achieve your weight loss goals, maintain good tolerability, and your provider confirms adequate clinical response at a lower dose like 1.0 mg, there is no requirement to continue advancing. Your PlexusDx provider personalizes your dosing plan based on your individual results, not a standardized protocol.

How does PlexusDx personalize dosing using genetic testing?

PlexusDx offers the Precision Peptide Genetic Test, which analyzes genetic variants in GLP-1 receptor pathways (like GLP1R rs6923761 and GIPR rs1800437) that influence your medication response. This peptide-pathway genetic test helps your provider anticipate your likely response to semaglutide and other GLP-1 compounds, enabling faster dose optimization tailored to your unique genetic profile.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves